-
Conference Date
November 22 - 23, 2023
-
Advanced Registration Deadline
November 21, 2023
-
On-Site Registration Date
November 21, 2023
Speakers
Chen WANG
Chinese Academy of Medical Sciences Peking Union Medical College
Welcome address
Laura Hassink
Managing Director of STMJ in Elsevier
Welcome address
Laura Hassink is Managing Director for STM Journals. In that capacity she is responsible for Elsevier's portfolio of 2,800 journals managed by more than 30,000 editors, who collectively publish more than 600,000 research articles a year. She leads a team of nearly 1400 people worldwide.
Laura recently joined the Board of STM, the International Association of Scientific, Technical and Medical Publishers. Prior to that Laura has been active as a board member of the Dutch Publishers Association. She holds a Master’s degree in Economics from Vrije Universiteit, Amsterdam, and a Bachelor's degree in Business Administration from Nyenrode Business University, The Netherlands.
Richard Horton
Editor-in-Chief & Publisher, The Lancet
Welcome address
Richard Horton qualified in physiology and medicine with honours from the University of Birmingham in 1986. He joined The Lancet in 1990, moving to New York as North American Editor in 1993.
In 2016, he chaired the Expert Group for the High Level Commission on Health Employment and Economic Growth, convened by Presidents Hollande of France and Zuma of South Africa. From 2011 to 2015, he was co-chair of the UN's independent Expert Review Group on Information and Accountability for Women's and Children's Health. In 2011, he was elected a Foreign Associate of the US Institute of Medicine and, in 2015, he received the Friendship Award from the Government of China. In 2019, he was awarded the WHO Director-General’s Health Leaders Award for outstanding leadership in global health and the Roux Prize in recognition of innovation in the application of global health evidence. In 2021, he received the Physicians for Human Rights Award in recognition of extraordinary leadership in advancing health and human rights.
He now works to develop the idea of planetary health – the health of human civilizations and the ecosystems on which they depend. In 2020, he published The COVID-19 Catastrophe: What’s Gone Wrong and How to Stop It Happening Again. A revised, updated, and expanded second edition was published in 2021. As part of the UK’s 2023 Honours, Dr Horton was awarded the Order of the British Empire (OBE) in recognition for services to Health and Medical Journalism.
Margaret Chan
Speaker
Dr Margaret Chan
Kun TANG
Tsinghua University Vanke School of Public Health
Speaker
Dr. Kun Tang, Associate Professor, Vanke School of Public Health, Tsinghua University. Deputy Director of Tsinghua University Department of International Cooperation. His research interests include global health, development aid for health and maternal and child health. He is currently the co-chair of the World Health Organization Global Advisory Group on Adolescent Health Metrics, and a member of the World Health Organization COVID-19 Global Research Roadmap Social Science Group. He has extensive working experience on a number of global health innovation projects in Kenya, Tanzania, D.R. Congo, Myanmar, Zimbabwe, and Papua New Guinea. He obtained his M.B.B.S. from Peking University, a Master’s in Global Health from Harvard University, and D.Phil. from the University of Oxford.
Michael Phillips
Shanghai Jiao Tong University School of Medicine
Speaker
Professor Phillips is a Canadian psychiatrist who has been a permanent resident of China for over 35 years. He is currently Director of the Suicide Research and Prevention Center at the Shanghai Mental Health Center, Professor of Psychiatry at Shanghai Jiao Tong University, Executive Director of the WHO Collaborating Center for Research and Training in Suicide Prevention at Beijing Hui Long Guan Hospital, Clinical Professor of Psychiatry and Epidemiology at Columbia University, Distinguished Professor at Central South University, and co-chair of the Lancet Commission on Mental Health in China.
He coordinates multi-center collaborative projects on suicide, depression and schizophrenia; runs research training courses for Chinese and foreign graduate students; promotes increased awareness of the importance of addressing China’s suicide problem; and advocates improving the quality, comprehensiveness and access to mental health services around the country. In 2013 he received China’s highest honor for scientific achievement for foreign nationals and in 2014 he received the Order of Canada.
Yi SONG
Institute of Child and Adolescent Health at Peking University
Speaker
Yi Song, associate professor and doctoral supervisor, is the director of Institute of Child and Adolescent Health at Peking University, and she also serves as the director of the Center for Child and Adolescent/School Health of the Chinese Center for Disease Control and Prevention at the same time, as well as the associate editor-in-chief of the international, peer-reviewed journal titled Future, and other academic appointments. Her research interests focus on the child and adolescent health and development, especially the evaluation of main health issues, early prevention and intervention of chronic diseases, and implementation research. She is the PI of more than 30 projects and has published over 150 academic articles as the first or corresponding author, 63 of those were in international journals, such as The Lancet Global Health, The Lancet Diabetes and Endocrinology, and The Lancet Child and Adolescent Health.
Jun MA
Radiation Oncology and deputy president of Sun Yat-sen University Cancer Center
Speaker
Jun Ma is a professor of Radiation Oncology and deputy president of Sun Yat-sen University Cancer Center. The main research interest of Prof. Ma is prognosis prediction and comprehensive treatment of nasopharyngeal carcinoma (NPC). He has done a solid job in improving the TNM staging system and investigating novel therapeutic strategies for nasopharyngeal carcinoma. He has been the Principal or Co-Principal Investigator of several multi-center clinical trials and translational research projects. As the first author and/or corresponding author, Prof. Ma has published over 140 papers in prestigious, international peer-reviewed journals, such as NEJM, Lancet, JAMA, BMJ, Nat Med, Lancet Oncol, J Clin Oncol, and so on. As the team leader, he has won the Second Prizes of the National Awards for Progress in Science and Technology in 2009/2015.
Yingxian SUN
Department of Cardiology of the First Hospital of China Medical University
Speaker
Yingxian Sun, director of the Department of Cardiology of the First Hospital of China Medical University, director of the Teaching and Research Section of Internal Medicine, the academic leader of internal medicine of China Medical University, academician of the International Eurasian Academy of Sciences, Level-2 professor, chief physician, doctoral supervisor, Doctor of Medicine.
Lili SONG
Speaker
Dr. Lili Song MD PhD, is the Head of Stroke Program, senior research fellow at The George Institute for Global Health (TGI), and senior lecturer at Faculty of Medicine, University of New South Wales. She has been a neurologist for 15 years and focused on clinical research for more than 10 years. Her research interest is in the treatment and prevention of acute stroke, in particular of blood pressure management around stroke. She has been leading several large-scale clinical trials in stroke area including INTERACT3, INTERACT4, ENCHANTED-2/MT, LATE-MT, CHAIN and ASPIRING as co-PI, co-investigator, or Project lead.
She is also sitting on Steering Committee or Data Safety Monitoring Board for several large clinical trials. She has published more than 50 publications on high impact clinical journals including NEJM and Lancet. She has successfully awarded an MRC joint funding in 2019 as well as MRFF grants in 2022 and 2023. She is a reviewer for several high-ranking clinical journals including Lancet, Stroke, Cerebrovascular Diseases, International Journal of Stroke, SVN, etc. She was authored or co-authored Review, Editorial or commentary for JAMA, Lancet Neurology, Stroke, etc. She was a visiting fellow at The University of Sydney in 2012-2013. She has been selected one of 2018 Emerging Leaders by the World Heart Foundation.
Ruitai SHAO
Chinese Academy of Medical Sciences Peking Union Medical College
Moderator
Prof Ruitai Shao joined the World Health Organization (WHO) in Sept 2001 as a high-level expert and has been providing technical guidance and advice on NCD prevention and control with focus on national NCD plans, polices and NCD research & innovation for countries. He has also been working with the selected countries to identify GAPs, barriers and challenges in prevention and control of noncommunicable diseases，and develop implementation strategies to address these issues in order to achieve better impact of implementing the cost-effective interventions and NCD targets and SDG3.4. Prior to this, he coordinated the WHO global forum on NCD prevention and control and managed the integrated NCD prevention and control program.
Prof Ruitai Shao was a senior public health specialist, vice president of Chinese Academy of Preventive Medicine (CAPM) and also was Deputy Director-General of department for the prevention and control of both communicable and noncommunicable diseases (NCDs) and public health strategies, policies and plans in Ministry of Health.
Prof Ruitai Shao holds a medical degree in medical science and a master’s degree in social medicine & health management from Peking University, and a PhD in public health management from Fudan University in Shanghai.
Helena WANG
Asia Executive Editor, The Lancet
Chair
Helena Wang is the Asia Senior Executive Editor of The Lancet. She led several editorial projects including The Lancet-Chinese Academy Medical Sciences Medical Conferences, The Lancet China themed issues, The Lancet China relevant Commissions, and The Wakley- Wu Lien Teh prize, and etc. She was also a Council Member of COPE (Committee of Publishing Ethics) from 2016-2019.
Yuankai SHI
Chinese Academy of Medical Sciences and Peking Union Medical College
Speaker
Yuankai Shi, MD, professor of medical oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College. The tenure-track professor of Chinese Academy of Medical Sciences & Peking Union Medical College. Member of the advisory committee of the New Drug Evaluation, National Medical Products Administration, China. International Adversary Board member of The Lancet Oncology (2017.11-2020.12).
As the principal investigator or participator, he has taken part in over 400 clinical trials and related research projects of anti-cancer drugs and completed the pivotal registration trails for 10 domestic anti-cancer new drugs or biosimilars and made them approved on the market. As the first and/or corresponding author including co-first and/or co-corresponding author, he has published over 400 articles in the international or domestic medical journals. Highly Cited Chinese Researchers by Elsevier in 2020, 2021 and 2022. The World’s Top 2% Scientists in 2021, 2022 and 2023.
Rongchang CHEN
Shenzhen People’s Hospital
Speaker
Rongchang CHEN, Professor of Medicine
Director, Shenzhen Institute of Respiratory Diseases, Shenzhen People’s Hospital; Former Director, Guangzhou Institute of Respiratory Health; Past President of Chinese Thoracic Society; Vice President of Chinese Alliance of Chest Physicians
Positions in Academic Institutes
Past President, Chinese Thoracic Society (2019.12—2022.12)
Vice President of Chinese Alliance of Chest Physicians (2021-2024)
Past President, Assembly of Respiratory Disease, Chinese Association of Medical Equipment
Fellow of American Chest Physician (Governor of China Representatives 2014);
Member of Director Board of GOLD (since 2014);
Past President of Respiratory Society of Guangdong Province Medical Association;
Associated Chief Editor: Chinese Journal of Tuberculosis and Respiration; Clinical
Respiratory Journal; Chest (Chinese Version);
Main research area: Airway disorders, Respiratory mechanics, Viral infection in pulmonary
diseases. Publications over 100 papers.
Bin CAO
Vice President, China-Japan Friendship Hospital
Executive Vice President, Institute of Respiratory Diseases, Chinese Academy of Medical
Speaker
Dr. Cao Bin, M.D., Chief Physician, Professor, Doctoral Supervisor, Vice President of the China-Japan Friendship Hospital, Director of the Department of Pulmonary and Critical Care Medicine (PCCM), Deputy Director of the National Respiratory Medical Center, Vice Director of the Institute of Respiratory Medicine at the Chinese Academy of Medical Sciences, and New Cornerstone Investigator. He holds the distinguished title of Changjiang Scholar Distinguished Professor and is a recipient of the Distinguished Young Scientist Fund by National Science Foundation of China.
Currently, he is the Chairman-elect of the Chinese Thoracic Society, the Scientific Advisory Committee member of Chinese Academy of Medical Sciences. Dr. Cao Bin has a long-standing commitment to research in critical scientific issues related to acute respiratory tract infections and emerging respiratory infectious diseases. As the first/corresponding author (including co-authors), he has authored over 190 SCI papers, including 4 in the NEJM, and 6 in The Lancet. His work has been cited for more than 38,000 times.
Speaker
Feng-Cai Zhu is an expert in clinical vaccinology, the deputy Director of Jiangsu Provincial Center for Disease Control and Prevention, a member of WHO Expert Group on COVID-19, the president of Vaccine Clinical Research Sub-group in China Association for vaccines, the President of Vaccine Clinical Research Committee in Chinese Preventive Medicine Association, and a member of National Drug Review Expert. He is the first level qualified personnel in Jiangsu province "333 project", and "National Tens of Millions of Talents Project“.
The Lancet published a profile: “Feng-Cai Zhu: leading vaccine evaluation in China”.
He has hosted national technology major projects, “863” projects, and other major projects at the provincial or ministerial level or above, and has received 7 provincial and ministerial-level science and technology awards. Among them, they have won two first prizes of the Jiangsu Provincial Science and Technology Award as the first contributor. He has published a total of 245 major papers in high-level academic journals including The Lancet(8), The Lancet Respira Med(3), NEJM(3), The Lancet Infect Dis(5), The Lancet Global Health(1), Nat Med(2), and Nat Commun(2). Among them, 11 papers are highly cited ESI papers.
Emma Grainger
Editor-in-Chief, The Lancet
Speaker
Emma Grainger completed a degree and a masters in Biochemistry at The University of Oxford, have a masters in Biotechnology from University College, London, and a doctorate on cancer viruses from St Mary’s Medical School, Imperial College, London. She also held a post-doctoral post at The Institute of Cancer Research linked to the Brompton Hospital in London. Her first editorial role at Elsevier in 1999 was working for The European Journal of Cancer as a Scientific Editor. She joined The Lancet group in 2005, working for The Lancet Oncology as a Senior Editor and then as Deputy Editor from 2008, and is the founding Editor-in-Chief of The Lancet Respiratory Medicine, which launched in March 2013, so the journal has recently celebrated its 10-year anniversary. She has also held Acting Executive Editor roles at The Lancet Haematology and eClinicalMedicine.
Jieming QU
Moderator
QU Jieming, Doctor of Medicine, Chief Physician of Pulmonary and Critical Care Medicine, Professor.
Doctoral and Postdoctoral Supervisor, Leading Talent in Shanghai
Currently serving as the Director of the Academic Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
President of Chinese Thoracic Society, Deputy President of Chest Physicians Society of Chinese Medical Doctor Association, President of Chest Physicians Society of Shanghai Medical Doctor Association, the 10th President of Respiratory Diseases Society of Shanghai Medical Association, Director of Shanghai Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases, and Director of the Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine.
Editor-in-Chief of the Chinese Journal of Tuberculosis and Respiratory Diseases, Deputy Editor-in-Chief of the Chinese Journal of Internal Medicine, Deputy Editor-in-Chief of the Chinese Journal of Medical Humanities, Deputy Editor-in-Chief of Science Bulletin.
Professor Qu Jieming has long been committed to clinical and basic research on complicated and critical respiratory diseases.
As the principal investigator, he has undertaken more than ten national projects, including 7 Chinese National Natural Science Foundation projects (including 1 key project), 1 National Key Research and Development Program project, and 2 sub-projects of the National Key Basic Research Program of the Ministry of Science and Technology.
Professor Qu Jieming has received the First Prize of Shanghai Science and Technology Progress Award, the Second Prize of Science and Technology Progress Award of the Ministry of Education, and the Second Prize of Shanghai Science and Technology Progress Award, totaling 9 scientific and technological achievement awards. He has published more than 130 SCI papers as the first author or corresponding author in internationally authoritative journals such as Cell, The Lancet, BMJ, Cell Research, NC, JEV, AJRCC, JCI, PNAS, and ERJ, with an impact factor of over 1100 and nearly 30,000 total citations. He has edited or co-edited 10 monographs, including the English version of "COV1D-19: THE ESSENTIALS OF PREVENTION AND TREATMENT," which is the first English monograph published by Chinese scholars in the field of COVID-19 prevention and treatment, published by Elsevier.
Dan XIAO
China-Japan Friendship Hospita
Institute of Respiratory Medicine, Chinese Academy of Medical Sciences
Moderator
Prof Xiao graduated from Norman Bethune University of Medical Science. completed her medical training and her PhD at Chinese Medical University. She has been a postdoctoral fellow at Capital Medical University (Beijing, China) and Harvard School of Public Health (Boston, MA, USA).
She is currently Director of Department of Tobacco Control and Prevention of Respiratory Disease, China-Japan Friendship Hospital and Co-head of WHO Collaborating Centre for Tobacco Cessation and Respiratory Diseases Prevention. She also acts as senior PI in China National Center for Respiratory Medicine, Institute of Respiratory Medicine of Chinese Academy of Medical Sciences, and National Clinical research Center for Respiratory Diseases. Her research interests are tobacco medicine, as well as respiratory diseases prevention. She has published over 100 papers and acted as a leading author of the Chinese Clinical Guidelines on Smoking Cessation, and China Report on Health Hazards of Smoking. Her research has influenced the clinical practice of cessation treatment and policy in China. As a clinician she has personally treated several thousand dependent smokers and helped to establish a national tobacco cessation network in China and Asia-Pacific area.
Xuming JIA
Senior Editor, eBioMedicine
Speaker
Xuming Jia, Senior Editor, eBioMedicine
Dr. Jia Joined eBioMedicine as a Senior Editor in 2019, She competed a PhD in Pharmacology at the University of Saskachewan, Canada, studying H2S homeostasis and its role in insulin resistance. This is followed by a postdoc based at Harvard T.H. Chan School of Public Health, where she investigated cellular and molecular mechanisms of iron homeostasis, and the effects of iron deficiency/accumulation in inflammatory response and metabolic disorders. Prior to joining eBioMedicine, she was a Scientific Editor of Science Bulletin from 2014 to 2019. Her current interests include all areas of translational medical research and global public health, with a particular focus on innovative treatments and diagnostic methods of different diseases.
Peng ZHANG
Speaker
Dr. Peng Zhang joined eBioMedicine, part of THE LANCET Discovery Science, in 2020, and is now serving as Senior Editor. Before joining eBioMedicine, he worked in Springer and later Springer Nature as an associate editor, editor and senior editor. Dr. Peng Zhang obtained his doctor degree of Molecular and Cellular Pathology at University of Michigan, Ann Arbor, studying the molecular regulatory mechanisms of renal fibrosis.
Till Bärnighausen
Speaker
Xi LI
Fuwai Hospital Chinese Academy of Medical Sciences
Speaker
Ningli WANG
Beijing Tongren Hospital, Capital Medical University
Speaker
Professor Wang Ningli is a member of the Chinese Academy of Medical Sciences, Director of the Beijing Tongren Eye Center, Dean of the School of Ophthalmology at Capital Medical University, and Director of the National Center for Engineering and Technology Research in Ophthalmology. He has served as the former Chairman of the Ophthalmology Branch of the Chinese Medical Association, is an Academician of the International Academy of Ophthalmology, and has been the former Chairman of the Asia-Pacific Academy of Ophthalmology. He has been selected as one of the world's top 100 most influential ophthalmologists five times and is ranked fourth in academic influence in the field of ophthalmology in the Asia-Pacific region. He has also been continuously recognized in the Elsevier "Highly Cited Scholars in China" list for nine consecutive years. Recently, he was elected as the incoming President of the World Glaucoma Association.
Professor Wang has been devoted to the research of diagnosis and treatment techniques for glaucoma, a leading cause of irreversible blindness worldwide, and national major eye disease prevention and control. He has published 312 SCI papers as the first or corresponding author, 411 Chinese papers, with 11,711 citations and an H-index of 61. He has published 31 papers in top-tier journals such as Nature, JAMA, and The Lancet, and 94 papers in ophthalmology journals in the JCR Q1 category.
Simiao CHEN
Research Unit for Population Medicine, Economics and Policy at Heidelberg Institute of Global Health at Heidelberg University
Chinese Academy of Medical Sciences Peking Union Medical College
Speaker & Moderator
Prof. Simiao Chen
Associate Professor (tenured), Heidelberg Institute of Global Health at Heidelberg University Head of Research Unit, Heidelberg Institute of Global Health at Heidelberg University Visiting Professor, Chinese Academy of Medical Sciences & Peking Union Medical College Alexander von Humboldt Research Fellow Faculty, the German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes) Commissioner, Lancet commission on investing in health Dr. Simiao Chen is an Associate Professor (tenured) and a Head of Research Unit for Population Medicine, Economics and Policy at Heidelberg Institute of Global Health at Heidelberg University in Germany, a Visiting Professor at Chinese Academy of Medical Sciences & Peking Union Medical College in China and an Alexander von Humboldt Research Fellow. Her primary areas of research include population medicine, health policy and health systems, health economics, as well as health psychology and behavioral science, mainly focusing on: (i) developing, analyzing, testing, and evaluating population medicine and public health interventions and policies that address large healthcare needs, such as COVID-19, hypertension, COPD, and mental health condition; (ii) the interrelations between health status, society and economic growth; and (iii) health system reforms. Her research has been funded by the Alexander von Humboldt Foundation, German Research Foundation (DFG), Horizon Europe from European Commission, National Natural Science Foundation of China, Bill & Melinda Gates Foundation, China Medical Board, National Institutes of Health (NIH), and Pan American Health Organization.
Andres Pichon-Riviere
Institute for Clinical Effectiveness and Health Policy (IECS), National Scientific and Technical Research Council
Speaker
Prof. Andres Pichon-Riviere MD Msc PhD, is a Physician, graduated from the University of Buenos Aires (UBA). He has a Master of Sciences in Clinical Epidemiology from Harvard University and a PhD in Public Health (UBA). He received training in disease modeling and economic evaluation methods at University or York and the London School of Hygiene and Tropical Medicine.
Andres is the Executive Director and Director of the Health Technology Assessment (HTA) and Economic Evaluations Department of the Institute for Clinical Effectiveness and Health Policy (IECS) and Director of the WHO/PAHO collaborating center in HTA. The IECS is an independent, non-for-profit organization devoted to research, education and technical support with the main goal of improving efficiency, equity, and quality of health care systems and policies in Argentina and Latin America. IECS is one of the leading Latin American Health Technology Assessment (HTA) Agencies, with more than 1000 HTA reports and economic evaluations published in the last fifteen years and indexed in the Centre for Reviews and Dissemination Database. He is also Full Professor of Public Health at the University of Buenos Aires, researcher at the National Scientific and Technical Research Council (CONICET), and Director of the courses of HTA for Decision Makers, HTA Postgraduate Course, and Economic Evaluation Modeling Introductory and Advanced Courses.
He has conducted several training, research and implementation projects in HTA and health economic evaluations in cooperation with government agencies, academic and private institutions in Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, El Salvador, Ecuador, Honduras, Mexico, Panama, Peru, Uruguay, and Venezuela. In 2008 was awarded the Global Health Leadership Award from the Global Health Research Initiative in recognition of his career in public health in Latin America.
He was Vice-Chair of the International Network of Agencies for Health Technology Assessment (INAHTA) between 2010 and 2014, and member of the board of Directors of Health Technology Assessment International (HTAi) between 2012 and 2015.
His recent work has involved the development of priority setting mechanisms and health benefits packages, and the establishment and training of health technology assessment agencies in developing countries. His most recent research has focused on the cost-effectiveness of vaccines, public health interventions, and oncologic drugs; and in the analysis of the health and economic impact of public policies in the area of chronic diseases.
Md. Mizanur Rahman
Research Center for Health Policy and Economics at Hitotsubashi University
Speaker
Mizanur Rahman, MSc, PhD, is a Professor (Associate) at the Research Center for Health Policy and Economics at Hitotsubashi University in Japan. He received his PhD in Global Health from the University of Tokyo's department of Global Health Policy. Before coming to Hitotsubashi in 2021, he worked as an Assistant Professor at the University of Tokyo and Associate Professor at the University of Rajshahi in Bangladesh. His expertise includes topics such as universal health coverage (UHC), health financing and policy evaluation, equity in health, maternal and child health, and systematic review and meta-analysis in global health. He has authored more than 50 peer-reviewed papers, and has won numerous academic awards. As well as his academic work, Mr. Rahman has regularly collaborated with international researchers from the World Health Organization and the Global Public Health Research Foundation in Bangladesh.
Pinyue JIN
Senior Editor, The Lancet Global Health
Speaker
Dr. Pingyue Jin is a Senior Editor of The Lancet Global Health since February 2022. Before joining The Lancet Group, she was an assistant professor first in the School of Public Health and later in the School of Health Policy and Management at the Chinese Academy of Medical Sciences/Peking Union Medical College. She completed the PhD in Biomedical Ethics and Law at the University of Zurich in 2014. Pingyue has a broad interest in global health and population health sciences, with a special focus on health equity, social determinants of health, ageing, and implementational science research.
Wenjia CAI
Department of Earth System Science, Tsinghua University
Speaker
Wenjia Cai is professor of global change economics in Department of Earth System Science, Tsinghua University, China. Her research group is particularly focusing on the health and economic impacts of action and inaction on climate change, as well as how these impacts are distributed among different regions and groups of people. She is also working on the design of carbon peaking and carbon neutrality pathways. Her papers were published in the Lancet, Nature, Lancet Public Health, Lancet Planetary Health and other high-impact journals. She is now the director of The Lancet Countdown Regional Centre for Asia and is one of the leading authors of the China Lancet Countdown Report on Health and Climate Change. She also serves as a member of Global Air Pollution and Health - Technical Advisory Group of the World Health Organization.
Speaker
Yunning Liu, associate professor in National Center for Chronic Noncommunicable Diseases Control and Prevention, Chinese Center for Disease Control and Prevention. Her research fields primarily include death monitoring, disease burden assessment, and life expectancy measurement. She has been involved in several significant projects, such as the National Science and Technology Support Program, the National Key Research and Development Program, the National Natural Science Foundation, and the National Social Science Foundation. She played a pivotal role in the "Research and Application on of Burden of Disease among Chinese Population " project, which earned the first prize of the Huaxia Medical Science and Technology Award. She has published several papers in work-leading journals as the first author, such as The Lancet Public Health. Additionally, she serves as a member of the third Committee of the Public Health Management Branch of the Chinese Preventive Medical Association.
Chi-Man (Winnie) Yip
Harvard University
Speaker
Dr. Winnie Yip is currently Professor of Global Health Policy and Economics in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health, serves as the Faculty Director of the school wide China Health Partnership, and recently completed her appointment as Acting Director of the Fairbank Center for Chinese Studies at Harvard University. Dr. Yip was previously a Professor of Health Policy and Economics at the Blavatnik School of Government, University of Oxford.
In addition to her academic appointments, Dr. Yip is also a member of the National Committee on United States-China Relations (NCUSCR) Track II Health Dialogues and is immediate past President of the International Health Economics Association (iHEA). She has consulted for numerous international agencies including the World Bank and the World Health Organization.
Dr. Yip holds a Ph.D. in Economics from the Massachusetts Institute of Technology. She is Senior Editor for Health Policy of Social Science and Medicine, an Associate Editor of Health Systems & Reform, and was previously Associate Editor of Health Economics.
Wanqing CHEN
Cancer Hospital Chinese Academy Of Medical Science
Speaker
Chen Wan-qing, Director, Office of Cancer Screening, National Cancer Center. Dr. Chen has theoretical basis and practical experience in cancer epidemiology area. He is PI of some nationwide studies.
He is the chairman, Branch of Cancer Screening and Early Dectection, Anti-Cancer Association of China; The member of Anti-Cancer Association of China; The member of Chinese Preventive Medicine Association; Editorial Director, vice Editor in Chief of Journal of China Cancer; Associate Editor of Journal of Epidemiology; Associate Editor of Journal of Epidemiology; Associate Editor of Chinese Journal of Cancer Research. He has published more than 300 scientific articles and 13 monographs.
Audrey Ceschia
Editor-in-Chief, The Lancet Public Health
Moderator
Audrey Ceschia joined The Lancet Group in 2008 as a Senior Editor. Since 2016, She is the founding Editor-in-Chief of The Lancet Public Health—committed to tackling the most pressing and neglected issues across all aspects of public health. In line with the values and vision of The Lancet, she has a strong commitment to using science as an important means to improve health equity.
Weizhong YANG
Executive Dean of the School of Population Medicine & Public Health
Chinese Academy of Medical Sciences Peking Union Medical College
Moderator
Prof. Yang Weizhong, Executive Head, School of Population Medicine & Public Health, Chinese Academy of Medical Sciences/Peking Union Medical College Vice President and Secretary General of Chinese Preventive Medicine Association, Former Deputy General Director of Chinese Center for Disease Control and Prevention.
Since 1982, he has been engaged in infectious disease surveillance, prevention and control, immunization planning management, and public health management in Sichuan Provincial Epidemic Prevention Station, Chinese Center for Disease Control and Prevention, and Chinese Preventive Medicine Association. In recent 10 years, as the first author or corresponding author, he has published more than 50 papers in international and journals such as The New England Journal of Medicine, Lancet, Vaccine, Public Health, PLoS ONE, Emerging Infectious Disease, BMJ, PLoS Medicine, Health Affairs, BMC Infectious Diseases etc. He edited the Early Warning for Infectious Disease Outbreak: Theory and Practice published by Elsevier He was the editor-in-chief of the Lancet Infectious Diseases Volume (Chinese Version), and the deputy editor of the Vaccine. (Chinese Version).
Youfa WANG
Xi’an Jiaotong University Health Science Center
Speaker
Youfa Wang, PhD, MD, MS, FTOS
National Distinguished Professor, Vice President of Xian Jiaotong University Health Science Center, Dean of Global Health Institute; President of the Obesity Prevention and Control Section of Chinese Nutrition Society, Vice President of the Society on Behavioral Health of Chinese Society of Preventive Medicine, Vice President of the Chinese Society on Global Health of Chinese Society of Preventive Medicine. In 2022, he was ranked 1,929th among the world's top 100,000 scientists in the Global Scholars Database, ranked 11th in the field of medicine in China.
Before returned to work in China full time in 2020, he worked as Founding Director of Global Center on Childhood Obesity Prevention and Control at Johns Hopkins University in the U.S., as Department Chair of State University of New York, Chair of the American Society for Nutrition (ASN) Nutritional Epidemiology Section, Chair of The Obesity Society (TOS) Pediatric Obesity Section (POS), and as a consultant for the WHO and the United Nations. As Principal Investigator (PI), he has directed several large international collaboration projects, including won a $16.1 million USA NIH U54 international collaboration research center grant on prevention and control of childhood obesity and chronic diseases. He has more than 360 publications, including in JAMA and Lancet. Several of his papers are cited for >1000 times respectively. He led published “The China Blue Paper on Obesity Prevention and Control (2019)” and “The Expert Consensus on Obesity Prevention and Treatment in China (2022)”.
John JI
Tsinghua University Vanke School of Public Health
Speaker
John Ji is an Associate Professor at Tsinghua University Vanke School of Public Health. He received his bachelor’s degree in neuroscience from Johns Hopkins University and his doctoral degree in environmental epidemiology from Harvard School of Public Health. John works with cohort studies on environmental determinants (green space, built environment, environmental pollution) of mortality and morbidities. He has published 150+ papers in journals such as The Lancet Regional Health - Western Pacific, The Lancet Planetary Health, International Journal of Epidemiology, and Environmental Health Perspectives. John was elected councillor of the International Society of Environmental Epidemiology (ISEE) – Asia Western Pacific Chapter. John teaches courses in research methods and epidemiology at Tsinghua University.
Lei ZHANG
Speaker
Prof Zhang is currently a Professor and the Director of the China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiatong University, China.
Prof Zhang received his PhD from the University of New South Wales, Australia in 2006 and has held positions at Humboldt University, Berlin, Germany, the UNSW, Australia and Monash University, Australia.
Prof Zhang is a very experienced epidemiologist and health economist. He has rich cross-disciplinary research experience in mathematics, epidemiology, artificial intelligence and health economics. To date, he has published 276 publications (261 papers, 6 book chapters, 9 technical reports), 186 of which are first/senior authored. He regularly publishes in leading journals (The Lancet HIV, The Lancet GH, The Lancet ID, The Lancet RH, Diabetes Care, Genetics in Medicine, International Journal of Epidemiology and Journal of Infections). His papers have been cited more than 8000 times. He presented 57 times at national/international HIV/STI conferences and 28 invited talks. He established the China-Australia Joint Research Center for Infectious Diseases in 2019 which facilitates a strong collaboration in education and research between Monash University and Xi’an Jiaotong University, China. The center has since published >130 papers and attracted $2.6m in grants.
He has supervised/is supervising 76 postdocs/postgraduates: 8 postdocs (2 completed), 26 PhD students (8 completed) and 43 master students (23 completed) funded by international, governmental and philanthropic grants, with a total of $7.2m. He was awarded "Humboldt Scholar" in Germany in 2007. His team was awarded China's Key Medical Development Award 2020, Chinese Academy of Medical Sciences and Australasian Sexual and Reproductive Health Alliance Innovation Award in 2021.
He has advised for Technical Working Group for Needle-Syringe Programs Evaluation in EECA at the World Bank (2013), the Strategic and Technical Advisory Committee for Viral Hepatitis at WHO (2014-2019), the Strategic and Technical Advisory Committee for Viral Hepatitis and at WHO Western Pacific (2018) and Immunization and Vaccines Related Implementation Research Advisory Committee at WHO Geneva (2022). He is a founding member of China's National Cervical Cancer Control Committee (since 2020) and the Working Committee of the Chinese Medical Association for Promoting the Elimination of Viral Hepatitis, China (since 2022).
Yunting ZHANG
Shanghai Jiao Tong University School of Medicine
Speaker
Yunting Zhang graduated from Shanghai Jiao Tong University School of Medicine with her MD degree in health economics in 2010 and her Ph.D. Degree of epidemiology in 2017. She worked in Harvard Medical School as visiting assistant professor in 2019. Right now, she is an associate professor as well as director of Global Child and Adolescent Health Division in Child Health Advocacy Institute of Shanghai Children’s Medical Center. Her major research interests are in pediatrics and child health. She is experienced in population assessment and monitoring of early childhood development, with special attention to the influence of socio-economic factors, family parenting style and lifestyles on early childhood development, as well as the practice and evaluation of related interventions. She is member of Early Child Development Committee of the Society of Pediatrics Chinese Medical Association, chief secretary of the Child Health Alliance of National Children’s Medical Center. She is also an Equity Initiative Fellow of China Medical Board and Atlantic Fellow by the Atlantic Philanthropies.
Qiya HUANG
Fuwai Hospital, Chinese Academy of Medical Sciences
Speaker
Qiya Huang, a PhD candidate at Peking Union Medical College, China Academy of Medical Sciences, Fuwai Hospital. She completed her undergraduate studies at Zhejiang University. Her doctoral mentor is Dr. Lei Song at Fuwai Hospital, China Academy of Medical Sciences. Her primary research focuses on cardiovascular disease genetics and precision cardiovascular medicine. Her research findings have been published in The Lancet Regional Health – Western Pacific and Circulation: Genomic and Precision Medicine.
Jie CAI
Editor-in-Chief, The Lancet Regional Health – Western Pacific
Speaker
Dr Jie Cai is the Editor-in-Chief of The Lancet Regional Health – Western Pacific, based in Beijing, China. Prior to joining the Lancet family of journals as China Senior Editor for eBioMedicine in 2019, she worked at Wiley as an editor for the Advanced Materials series peer review team. Her current interests lie at the intersection of emerging digital innovations that have the potential to improve people’s wellbeing, such as non-communicable diseases, health systems, and population health.
Miao WANG
Moderator
Dr. Wang got B.S. and M.S. degrees from Zhejiang University and obtained a Ph.D. degree from Chinese Academy of Medical Sciences in 2002. Dr. Wang completed postdoctoral research and obtained a Clinical Research Certificate in Clinical Epidemiology & Biostatistics at University of Pennsylvania, and then joined the Department of Pharmacology as Research Associate and Research Assistant Professor from 2006-2010.
Dr. Wang joined Pfizer Inc as Principal Scientist in 2010 and had been leading several cardiovascular drug discovery programs until he took the current position in 2013.
Dr. Wang is a fellow of American Heart Association (FAHA) and serves in the program committees for the American Heart Association (AHA) Scientific Sessions and for the Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions. He serves as editorial board member for “Redox Biology” and “Biochemical Pharmacology”.
Dr. Wang’s research aims to elucidate the mechanisms of coronary artery disease, with a particular focus on inflammation and thrombosis, and to translate novel mechanistic insights into therapeutic innovation. He discovers that the increased risk of thrombosis associated with cyclooxygenase-2 selective NSAIDs is attributable to suppression of COX-2 derived prostacyclin, and that inhibition of mPGES-1, a therapeutic target downstream of COX-2 pathway, can bypass the thrombotic risk and has therapeutic relevance for vascular restenosis and myocardial infarction. He uncovers that prostaglanding E2, through acting on its receptor EP4 on the endothelium, promotes microvascular salvage in myocardial ischemia/reperfusion, protecting against myocardial injury. Furthermore, he identified phorsphodiesterase-4B as a novel therapeutic target for acute myocardial infarction, which provides cardioprotection by both anti-inflammation and microcirculation preservation. He is chief editor of the book “Coronary Artery Disease: Therapeutics and Drug Discovery” (Springer Press).
Min DAI
Moderator
Dr Min Dai is the Professor in Cancer Epidemiology and Department Director of Scientific Research in National Cancer Center/Chinese Hospital, Chinese Academy of Medical Sciences (CHCAMS). She is also the Tenure-Track Professor of CAMS/PUMC.
Dr Dai’s research focuses on the Cancer Epidemiology and Cancer Prevention. In particular, she is specialized in Colorectal Cancer Screening and prospective cohort study. She led the National Key Public Health Program, National Key Research and Development Project, National Natural Science Fund Project, CAMS Medical and Innovation Project etc. She has published more than 150 papers in peer-reviewed journals such as Lancet Respiratory Diseases, Gut, Am J Gastroenterology, etc.
Zoë Mullan
Editor-in-Chief, The Lancet
Speaker
Zoë Mullan (London, UK)
Zoë Mullan is Editor-in-Chief of the open access journal The Lancet Global Health and Inclusion & Diversity Lead for The Lancet Group. She is an Ex-Officio Board Member of the Consortium of Universities for Global Health and a Scientific Advisory Board member of the Centre for International Health Protection at the Robert Koch Institute, Berlin, Germany. Between 2013 and 2017 she was a Council Member and Trustee of the Committee on Publication Ethics. She trained in Biochemistry at the University of Bath, UK, before joining the publishing industry in 1997 as a Scientific Information Officer with CABI. She moved to The Lancet in 1999, where she has worked since, variously as a technical editor, section editor, and founding editor of The Lancet Global Health.